Skip to content

Application of volume maintenance combined with hemodynamic support in immediate and delayed resuscitation protocols in severe burn injury

Application of volume maintenance combined with hemodynamic support in immediate and delayed resuscitation protocols in severe burn injury

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001493
Enrollment
Unknown
Registered
2011-08-14
Start date
2010-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

severe and extraordinarily severe burn

Interventions

A1:Immediate resuscitation + fructose sodium diphosph
A2:Immediate resuscitation + enalaprilat injection
B3:Delayed resuscitation + alprostadil injection
A4:Immediate resuscitation + conventional therapy
B4:Delayed resuscitation + conventional therapy
B2:Delayed resuscitation + enalaprilat injection
A3:Immediate resuscitation + alprostadil injection
B1:Delay resuscitation + alprostadil injection

Sponsors

South West Hospital affiliated to the 3rd Military medical university of People's Liberation Army
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Male or female patients aged 18-65 yrs; 2. Patients with burn injury caused by hot fluid, hot metal or fire. Chemical burn is excluded; 3. Patients with severe and extraordinarily severe burn (TBSA>30% or IIIdegree burn area >20%); 4. Immediate resuscitation group: patients were administrated in hospital within 5h after burn, or received pre-hospital systemic fluid resuscitation; Delayed resuscitation group: patients were administrated in hospital 6h after burn, or received no pre-hospital systemic fluid resuscitation; 5. Serum cTnI >0.15ug/L, or CK-MB>25IU/L.

Exclusion criteria

Exclusion criteria: 1. Patients with history of cardiovascular disease (such as severe congestive heart failure, sick sinus syndrome, II or III AV block, atrial flutter or fibrillation combined with AV bypass, using beta-blocker or digitalis toxication, ventricular tachycardia with QRS>=0.12s); 2. Patients with history of hypertension, hypotension, or wavy blood pressure; 3. Patients with severe disease in heart, kidney, liver, lung and other vital organs, including new myocardial infarction and myocardial damage; 4. Patients with mental disorder and epilepsy; 5. Pregnant or lactating women; 6. Patients were allergic or contradict to the trial drug; 7. Patients with poor adherence; 8. Patients that is eligible for the current study for other reason.

Design outcomes

Primary

MeasureTime frame
Rate of infection of wound, bacteria types, drug-resistance and use of antibiotics;Fluid resuscitation parameters: total fluid replacement volume in 48 hrs after burn and the composition;Organ damage parameters: myocardial enzyme, TBA, beta2-MG, DAO;

Secondary

MeasureTime frame
Shock-related parameters: heart rate, blood pressure, CVP, urine volume;Blood parameters: lactic acid, PaO2, HCT, WBC;

Countries

China

Contacts

Public ContactYuesheng Huang
hyues58@gmail.com+86 13608371707

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026